Can employers still test for cannabis?
Whether you can test for cannabis — and what you can do with a positive result — depends on (1) whether the role is DOT-regulated or federal-contractor-covered (yes, you must), (2) whether the role is safety-sensitive under state law (typically yes, you can), and (3) whether the role is non-safety-sensitive in a state that restricts employer cannabis testing (often no, or only narrowly). The pattern across recent state law has been a steady carve-out of off-duty cannabis use for non-safety-sensitive roles.
The federal floor
Federal law still classifies cannabis as a Schedule I controlled substance under the Controlled Substances Act. DOT-regulated employers must continue to test for cannabis on the DOT 5-panel. Federal contractors subject to the Drug-Free Workplace Act must maintain a drug-free workplace policy. Where a state cannabis statute conflicts with these federal obligations, federal law preempts.
Recurring state-law patterns
State cannabis-testing statutes vary widely, but recurring features include:
- Off-duty use protection. Employees may not be disciplined for lawful off-duty cannabis use absent evidence of on-duty impairment.
- Pre-employment carve-outs. Pre-employment cannabis testing is prohibited or restricted for non-safety-sensitive roles.
- Safety-sensitive exception. Roles designated safety-sensitive (typically by statute or by employer with a documented safety justification) remain testable.
- Federal-supremacy carve-outs. DOT-regulated and federal-contractor roles remain testable per federal law.
- Medical cannabis accommodation. Many states require employers to consider accommodation for off-duty medical cannabis use.
Impairment vs detection — the core tension
A persistent challenge in workplace cannabis policy is that a urine drug test does not measure impairment. THC-COOH (the urinary metabolite) can be detected for days to weeks after any psychoactive effect has ended in chronic users. State cannabis statutes increasingly recognize this and require an additional impairment determination beyond a positive test for non-safety-sensitive roles. The MRO process does not solve this — impairment is a behavioral, not a laboratory, question.
Programs that need to address current impairment (rather than recent use) often rely on a combination of reasonable-suspicion observation, oral-fluid testing (shorter window, more recent-use-weighted), and post-accident blood testing.
Designing a defensible policy
- Define safety-sensitive roles with specific, documented criteria (control of vehicles, machinery, hazardous materials, the safety of others).
- Separate DOT-regulated from non-DOT roles in policy language.
- Tie consequences to impairment where the role is non-safety-sensitive and state law restricts cannabis testing.
- Train supervisors to recognize and document on-the-job impairment indicators (which is also DOT-required for supervisors of DOT-regulated employees).
- Coordinate medical accommodation with the ADA interactive process where applicable.
Sources & references
drugtest.co content is sourced from primary regulatory and clinical references. We do not cite gray-market or "how to pass" sources.